Computational Methods for Protein Structures

Computational methods employing machine learning algorithms are powerful tools that can be used to predict the effect of mutations on protein structure. This is important in neurodegenerative disorders, where some mutations can cause the formation of toxic protein aggregations. This feed follows the latests insights into the relationships between mutation and protein structure leading to better understanding of disease.

November 10, 2020
Open Access

FireProtDB: database of manually curated protein stability data.

Nucleic Acids Research
Jan StouracDavid Bednar
November 3, 2020
Open Access

RNA inter-nucleotide 3D closeness prediction by deep residual neural networks

Saisai SunJianyi Yang
May 18, 2020
Open Access

Biased Gene Conversion Constrains Adaptation in Arabidopsis thaliana

Tuomas Hämälä, Peter Tiffin
August 23, 2020
Open Access

Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications

International Journal of Molecular Sciences
Konstantinos FarsalinosKonstantinos Poulas
December 18, 2020
Open Access

Moonlighting protein prediction using physico-chemical and evolutional properties via machine learning methods

Farshid ShirafkanJavad Zahiri
January 14, 2021
Open Access

Improving integrative 3D modeling into low- to medium- resolution EM structures with evolutionary couplings

BioRxiv : the Preprint Server for Biology
C. L. McCaffertyE. M. Marcotte
December 3, 2020
Open Access

A multi-task deep-learning system for predicting membrane associations and secondary structures of proteins

BioRxiv : the Preprint Server for Biology
BIAN LIJ. Meiler
December 17, 2020
Open Access

Genotype-phenotype map of an RNA-ligand complex

BioRxiv : the Preprint Server for Biology
O. PuchtaGrzegorz Kudla
October 24, 2020
Open Access

Machine Learning Enables Selection of Epistatic Enzyme Mutants for Stability Against Unfolding and Detrimental Aggregation

Chembiochem : a European Journal of Chemical Biology
Guangyue LiManfred T Reetz
August 4, 2020

A New Framework for Automatic Detection of Patients With Mild Cognitive Impairment Using Resting-State EEG Signals

IEEE Transactions on Neural Systems and Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society
Siuly SiulyFrank Whittaker
October 31, 2020
Open Access

AlignmentViewer: Sequence Analysis of Large Protein Families

Roc ReguantNicholas Paul Gauthier
June 5, 2020

Predicting the stability of mutant proteins by computational approaches: an overview

Briefings in Bioinformatics
Anna MarabottiAngelo Facchiano
October 22, 2020
Open Access

Machine learning techniques for mortality prediction in critical traumatic patients: anatomic and physiologic variables from the RETRAUCI study

BMC Medical Research Methodology
Luis ServiáJavier Trujillano Cabello
December 20, 2020
Open Access

Evolutionary coupling range varies widely among enzymes

BioRxiv : the Preprint Server for Biology
Julian Echave
July 21, 2020
Open Access

Machine learning through cryptographic glasses: combating adversarial attacks by key-based diversified aggregation

EURASIP Journal on Information Security
Olga TaranSlava Voloshynovskiy

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved